Organon Debt to Equity Ratio 2019-2025 | OGN
Current and historical debt to equity ratio values for Organon (OGN) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Organon debt/equity for the three months ending March 31, 2025 was 18.77.
| Organon Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-03-31 | $0.00B | 0.00 | |
| 2024-12-31 | $12.63B | $0.47B | 26.76 |
| 2024-09-30 | $12.26B | $0.49B | 24.87 |
| 2024-06-30 | $12.01B | $0.14B | 83.40 |
| 2024-03-31 | $11.84B | $0.05B | 246.73 |
| 2023-12-31 | $12.13B | $-0.07B | -173.26 |
| 2023-09-30 | $11.60B | $-0.59B | -19.70 |
| 2023-06-30 | $11.53B | $-0.56B | -20.78 |
| 2023-03-31 | $11.50B | $-0.74B | -15.60 |
| 2022-12-31 | $11.85B | $-0.89B | -13.28 |
| 2022-09-30 | $11.50B | $-1.07B | -10.79 |
| 2022-06-30 | $11.75B | $-1.14B | -10.34 |
| 2022-03-31 | $11.85B | $-1.25B | -9.48 |
| 2021-12-31 | $12.19B | $-1.51B | -8.08 |
| 2021-09-30 | $12.95B | $-1.62B | -8.01 |
| 2021-06-30 | $12.84B | $-1.93B | -6.64 |
| 2021-03-31 | $4.92B | $4.72B | 1.04 |
| 2020-12-31 | $4.62B | $5.49B | 0.84 |
| 2020-09-30 | $0.00B | $0.00B | 0.00 |
| 2020-06-30 | $0.00B | $0.00B | 0.00 |
| 2020-03-31 | $0.00B | $0.00B | 0.00 |
| 2019-12-31 | $3.51B | $7.04B | 0.50 |
| 2018-12-31 | $0.00B | $0.00B | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $2.493B | $6.403B |
| Organon is a healthcare company. It focuses on the health of women throughout their lives. Organon is based in JERSEY CITY, N.J. | |||